Gilles de la Tourette Syndrome.
Horn
S
S
Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D018492:Dopamine Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use; D010868:Pimozide / Q000627:therapeutic use; D019966:Substance-Related Disorders / Q000150:complications; D020323:Tics / Q000139:chemically induced; D005879:Tourette Syndrome / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000523:psychology
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D010868:Pimozide; D008774:Methylphenidate